RNU6-148P

Across TCGA pan-cancer cohorts, RNU6-148P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-148P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-148P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-148P expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

BLCA, UCEC, and STAD are the cancer types where RNU6-148P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.051	0.720	<.001	144	view →
UCEC	DFS	Tertile	All	0.240	0.842	<.001	90	view →
STAD	OS	Tertile	II,III,IV	0.159	0.566	.012	72	view →
LAML	DFS	Tertile	All	0.859	0.318	.010	18	view →
UVM	OS	Tertile	All	0.315	0.711	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-148P–BLCA (OS)

Open the BLCA breakdown →